Cite
HARVARD Citation
Zhang, J. et al. (n.d.). 2101 FOLFOXIRI versus FOLFOX/FOLFIRI plus Bevacizumab as first-line treatment in metastatic colorectal cancer: A systematic review and network Meta-analysis of phase III study. European journal of cancer. pp. S362-S363. [Online].